Sharps Technology Past Earnings Performance
Past criteria checks 0/6
Sharps Technology's earnings have been declining at an average annual rate of -32.2%, while the Medical Equipment industry saw earnings growing at 13.4% annually.
Key information
-32.2%
Earnings growth rate
-2.3%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | n/a |
Return on equity | -124.0% |
Net Margin | n/a |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Sharps Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 0 | -10 | 9 | 2 |
30 Sep 23 | 0 | -8 | 8 | 2 |
30 Jun 23 | 0 | -8 | 8 | 2 |
31 Mar 23 | 0 | -5 | 8 | 2 |
31 Dec 22 | 0 | -5 | 6 | 2 |
30 Sep 22 | 0 | -5 | 5 | 2 |
30 Jun 22 | 0 | -4 | 5 | 2 |
31 Mar 22 | 0 | -6 | 3 | 2 |
31 Dec 21 | 0 | -5 | 3 | 2 |
30 Sep 21 | 0 | -4 | 2 | 1 |
31 Dec 20 | 0 | -2 | 2 | 1 |
Quality Earnings: STSS is currently unprofitable.
Growing Profit Margin: STSS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: STSS is unprofitable, and losses have increased over the past 5 years at a rate of 32.2% per year.
Accelerating Growth: Unable to compare STSS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: STSS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: STSS has a negative Return on Equity (-124.04%), as it is currently unprofitable.